You are here

Article Text

Article menu

Download PDFPDF

Research Article
An improved diagnostic assay for Lambert-Eaton myasthenic syndrome.
  1. M Motomura,
  2. I Johnston,
  3. B Lang,
  4. A Vincent,
  5. J Newsom-Davis
  1. Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK.

    Abstract

    A new immunoprecipitation assay has been established for detecting antibodies to voltage-gated calcium channels (VGCCs) in Lambert-Eaton myasthenic syndrome (LEMS), using 125I-omega-conotoxin MVIIC, which binds to P-type VGCCs, to label extracts of human cerebellum. Fifty six of 66 serum samples (85%) from patients with clinically and electrophysiologically definite LEMS were positive for the presence of VGCC antibodies, defined as a titre > 3 SD above the mean for the healthy controls (n = 10). All disease controls (n = 40) were negative. This sensitive immunoassay should prove valuable in the diagnosis of LEMS.

    https://doi.org/10.1136/jnnp.58.1.85

    Statistics from Altmetric.com

      Request Permissions

      If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.